搜索临床试验以:ETBX-011
总计1029个结果
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
NantCell, Inc.完全的乳腺癌 | 胰腺癌 | 卵巢癌 | 肺癌 | 结肠癌 | 甲状腺癌美国
-
National Cancer Institute (NCI)完全的
-
ImmunityBio, Inc.主动,不招人
-
ImmunityBio, Inc.撤销
-
ImmunityBio, Inc.撤销
-
ImmunityBio, Inc.撤销
-
Celgene终止
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
Achieve Life Sciences完全的
-
University of British ColumbiaUnited States Department of Defense完全的
-
Novartis Pharmaceuticals完全的肾功能受损 | 肾功能正常美国, 德国, 保加利亚, 捷克语
-
Cellular Biomedicine Group Ltd.The First Affiliated Hospital with Nanjing Medical University完全的
-
CelgeneAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA完全的
-
M.D. Anderson Cancer CenterCureTech Ltd完全的